Gerald Chan

Insider Reports History

Location
Berkeley, CA
Signature
/s/ David Watson, attorney-in-fact for Gerald Chan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gerald Chan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Director Common Stock 25,666 $606,487 $23.63 01 Jan 2026 Direct
Apellis Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 14,684 $381,092 $66.30 01 Jan 2026 Direct

Insider Reports Filed by Gerald Chan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2026 2 $0 4 Director 05 Jan 2026, 16:38
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2025 2 $0 4 Director 03 Jan 2025, 16:12
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2024 2 +$344,075 4 Director 02 Jan 2024, 16:10
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2023 2 $0 4 Director 04 Jan 2023, 16:33
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2022 2 $0 4 Director 04 Jan 2022, 20:29